Education
About Us
Working with TipRanks
Follow Us
Zhengye Biotechnology Holding Ltd. (ZYBT)
NASDAQ:ZYBT
Total Valuation
Zhengye Biotechnology Holding Ltd. has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Zhengye Biotechnology Holding Ltd. has 47,391,376 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,391,376
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhengye Biotechnology Holding Ltd.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.98%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)8.98%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover0.42
Inventory Turnover1.40
Valuation Ratios
The current PE Ratio of Zhengye Biotechnology Holding Ltd. is 0.00. Zhengye Biotechnology Holding Ltd.’s PEG ratio is ―.
PE Ratio0.00
PS Ratio0.00
PB Ratio―
Price to Fair Value0.00
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Zhengye Biotechnology Holding Ltd. had revenue of 211.65M and earned 31.46M in profits. Earnings per share was 0.00.
Revenue211.65M
Gross Profit129.85M
Operating Income44.99M
Pretax Income43.76M
Net Income31.46M
EBITDA72.10M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Zhengye Biotechnology Holding Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.87
52-Week Price Change40.89%
50-Day Moving Average8.08
200-Day Moving Average―
Relative Strength Index (RSI)46.52
Average Volume (3m)605.02K
Important Dates
Zhengye Biotechnology Holding Ltd. upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Zhengye Biotechnology Holding Ltd. as a current ratio of 1.37, with Debt / Equity ratio of ―
Current Ratio1.37
Quick Ratio0.98
Debt to Market Cap0.00
Net Debt to EBITDA1.04
Interest Coverage Ratio10.17
Taxes
In the past 12 months, Zhengye Biotechnology Holding Ltd. has paid 6.25M in taxes.
Income Tax6.25M
Effective Tax Rate0.14
Enterprise Valuation
Zhengye Biotechnology Holding Ltd. EV to EBITDA ratio is 1.04, with an EV/FCF ratio of 2.04.
EV to Sales0.35
EV to EBITDA1.04
EV to Free Cash Flow2.04
EV to Operating Cash Flow1.55
Balance Sheet
Zhengye Biotechnology Holding Ltd. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$0.00
Margins
Gross margin is ―, with operating margin of 21.25%, and net profit margin of 14.86%.
Gross Margin―
Operating Margin21.25%
Pretax Margin20.68%
Net Profit Margin14.86%
EBITDA Margin34.06%
EBIT Margin22.77%
Analyst Forecast
The average price target for Zhengye Biotechnology Holding Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―